We are live on ! Find out more
FCP

Fidelis Capital Partners Portfolio holdings

AUM $1.4B
1-Year Est. Return 31.16%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+31.16%
3 Year Est. Return
+98.29%
5 Year Est. Return
10 Year Est. Return
AUM
$840M
AUM Growth
+$137M
Cap. Flow
+$16.6M
Cap. Flow %
1.98%
Top 10 Hldgs %
34.26%
Holding
430
New
52
Increased
220
Reduced
110
Closed
18

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$63M
2
V icon
Visa
V
+$921K
3
LLY icon
Eli Lilly
LLY
+$763K
4
BP icon
BP
BP
+$675K
5
CVS icon
CVS Health
CVS
+$652K

Sector Composition

Rank Sector Weight
1 Technology 22.64%
2 Financials 7.56%
3 Consumer Discretionary 6.51%
4 Healthcare 6.29%
5 Communication Services 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJR icon
26
iShares Core S&P Small-Cap ETF
IJR
$112B
$6.36M 0.76%
55,508
+15,524
+39% +$1.75M
LLY icon
27
Eli Lilly
LLY
$1.06T
$6.27M 0.75%
6,943
-849
-11% -$763K
CMG icon
28
Chipotle Mexican Grill
CMG
$41.5B
$6.2M 0.74%
105,052
+30,115
+40% +$1.67M
V icon
29
Visa
V
$677B
$6.03M 0.72%
21,262
-3,405
-14% -$921K
COWZ icon
30
Pacer US Cash Cows 100 ETF
COWZ
$19.4B
$5.43M 0.65%
95,019
+15,252
+19% +$855K
IJH icon
31
iShares Core S&P Mid-Cap ETF
IJH
$127B
$5.26M 0.63%
84,325
+1,595
+2% +$96.2K
JNJ icon
32
Johnson & Johnson
JNJ
$625B
$4.77M 0.57%
28,760
+2,155
+8% +$343K
CVX icon
33
Chevron
CVX
$366B
$4.74M 0.57%
31,527
-858
-3% -$128K
UNH icon
34
UnitedHealth
UNH
$370B
$4.72M 0.56%
8,356
+201
+2% +$114K
ABBV icon
35
AbbVie
ABBV
$435B
$4.65M 0.55%
24,745
+1,778
+8% +$332K
PANW icon
36
Palo Alto Networks
PANW
$297B
$4.55M 0.54%
25,392
+886
+4% +$149K
IWY icon
37
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$4.54M 0.54%
+20,493
New +$4.36M
MRK icon
38
Merck
MRK
$318B
$4.5M 0.54%
42,274
+1,298
+3% +$154K
HD icon
39
Home Depot
HD
$355B
$4.08M 0.49%
10,200
-46
-0.4% -$16.8K
PG icon
40
Procter & Gamble
PG
$339B
$4.02M 0.48%
23,691
+1,313
+6% +$223K
CALF icon
41
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.82B
$3.96M 0.47%
87,875
-2,273
-3% -$103K
AMD icon
42
Advanced Micro Devices
AMD
$789B
$3.78M 0.45%
24,701
+401
+2% +$60.9K
USMV icon
43
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
$3.7M 0.44%
40,301
-3,594
-8% -$317K
VEA icon
44
Vanguard FTSE Developed Markets ETF
VEA
$236B
$3.63M 0.43%
71,862
+48,158
+203% +$2.45M
CSCO icon
45
Cisco
CSCO
$479B
$3.59M 0.43%
63,799
+4,510
+8% +$219K
QCOM icon
46
Qualcomm
QCOM
$176B
$3.37M 0.4%
20,201
+1,196
+6% +$211K
CAT icon
47
Caterpillar
CAT
$387B
$3.35M 0.4%
8,684
+456
+6% +$157K
COP icon
48
ConocoPhillips
COP
$141B
$3.31M 0.39%
31,674
+705
+2% +$77.4K
IWS icon
49
iShares Russell Mid-Cap Value ETF
IWS
$16B
$3.26M 0.39%
24,701
+6,232
+34% +$788K
TSLA icon
50
Tesla
TSLA
$1.3T
$3.22M 0.38%
15,054
+904
+6% +$206K

Similar funds

Fidelis Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Fidelis Capital Partners held 430 positions worth $840M, up 20% from $702M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Fidelis Capital Partners's Q3 2024 filing shows 52 new, 220 increased, 110 reduced and 18 closed positions. Its largest new stake was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M. The largest sale was Broadcom, an estimated $63M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Fidelis Capital Partners's largest Q3 2024 buy was iShares Russell Top 200 Growth ETF: 20,493 shares worth $4.54M.
  • Fidelis Capital Partners added most to Lam Research in Q3 2024, an estimated $10.2M increase.
  • Fidelis Capital Partners's biggest Q3 2024 reduction was Broadcom, cutting an estimated $63M.
  • Fidelis Capital Partners fully exited Valaris in Q3 2024, selling an estimated $637K.
  • Fidelis Capital Partners's ten largest holdings make up 34% of its $840M portfolio in Q3 2024.
  • Fidelis Capital Partners opened 52 new positions and closed 18 in Q3 2024.
  • Fidelis Capital Partners's portfolio value rose 20% quarter-over-quarter to $840M.

Based on Fidelis Capital Partners's 13F filing for Q3 2024, filed 25 Oct 2024.